Position in CELC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,785,400
+$17,785,400 QoQ
Shares Held
170,000
Ownership
0.347%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#55
of 273 holders
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Derivatives in CELC
reported options exposure · as of Jun 30, 2026CallValue
$5,231,000
CallShares
50,000
PutValue
$28,467,102
PutShares
272,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. CELC ranks #4 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
This page
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in CELC
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,785,400 | 170,000 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $5,231,000 | 50,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $28,467,102 | 272,100 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $68,484,000 | 600,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $51,545,632 | 516,800 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $16,188,380 | 327,700 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $3,952,000 | 80,000 | Put | Sole | 2025-11-14 | |
| 2024-09-30 | $658,455 | 44,162 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $2,220,099 | 148,900 | Put | Sole | 2024-11-14 | |
| 2024-06-30 | $613,201 | 37,436 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $2,070,432 | 126,400 | Put | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||